Jessica Mega MD

Jessica Mega MD General Information

Biography

Dr. Jessica Mega is a Co-Founder of Verily Life Sciences. Dr. Mega previously served as Chief Medical and Scientific Officer at the company. She serves as a Board Member & Member of the Science & Technology Committee at Danaher. Prior to joining Verily Life Sciences, Dr. Mega served as Cardiologist and Senior Investigator at Brigham & Women's Hospital from 2008 to March 2015. She has also served as a faculty member at Harvard Medical School and a senior investigator with the TIMI Study Group, where she helped lead international trials evaluating novel cardiovascular therapies and directed the genetics program. Dr. Mega oversees the clinical and science efforts, focusing on translating technological innovations and scientific insights into partnerships and programs that improve patient outcomes. Her clinical background and experience re-imagining how clinical trial data is collected and analyzed offer valuable insights for Danaher, given our strategic focus on life sciences and healthcare applications. She was originally proposed to the Nominating and Governance Committee for election as a director by one of the Company's managing directors. She served as Verily's first Chief Medical and Scientific Officer, pioneering approaches that combined leading clinical and scientific capabilities with the best of technology and data science. She played a critical role in the creation of a patient-centered evidence generation platform used by multiple industry, academic, and advocacy partners, guided Verily's national response to the COVID pandemic, and developed products that apply next generation multidimensional health data to both research and clinical care.